Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79

Reference

Title : Galantamine provides sustained benefits in patients with 'Advanced Moderate' Alzheimer's disease for at least 12 months - Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79
Author(s) : Blesa R , Davidson M , Kurz A , Reichman W , Van Baelen B , Schwalen S
Ref : Dementia & Geriatric Cognitive Disorders , 15 :79 , 2003
Abstract : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79
ESTHER : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79
PubMedSearch : Blesa_2003_Dement.Geriatr.Cogn.Disord_15_79
PubMedID: 12566596

Related information

Citations formats

Blesa R, Davidson M, Kurz A, Reichman W, Van Baelen B, Schwalen S (2003)
Galantamine provides sustained benefits in patients with 'Advanced Moderate' Alzheimer's disease for at least 12 months
Dementia & Geriatric Cognitive Disorders 15 :79

Blesa R, Davidson M, Kurz A, Reichman W, Van Baelen B, Schwalen S (2003)
Dementia & Geriatric Cognitive Disorders 15 :79